Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Paranjape S.B.   Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 825-834

Informa Healthcare

Access to resources Recommend Favorite

[Arg 8 ]Vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists

By Bax W.A.   Van der Graaf P.H.   Stam W.B.   Bos E.   Nisato D.   Saxena P.R.  

European Journal of Pharmacology, Vol. 285, Iss. 2, 1995-10 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1549-1559

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan   Guglin Maya   Vaitkevicius Peter   Ghali Jalal K.  

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite